Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithms
Open Access
- 16 December 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-11
Abstract
Dyskinesias are non preventable abnormal involuntary movements that represent the main challenge of the long term treatment of Parkinson’s disease (PD) with the gold standard dopamine precursor levodopa. Applying machine learning techniques on the data extracted from the Parkinson’s Progression Marker Initiative (PPMI, Michael J. Fox Foundation), this study was aimed to identify PD patients who are at high risk of developing dyskinesias. Data regarding clinical, behavioral and neurological features from 697 PD patients were included in our study. Our results show that the Random Forest was the classifier with the best and most consistent performance, reaching an area under the receiver operating characteristic (ROC) curve of up to 91.8% with only seven features. Information regarding the severity of the symptoms, the semantic verbal fluency, and the levodopa treatment were the most important for the prediction, and were further used to create a Decision Tree, whose rules may guide the pharmacological management of PD symptoms. Our results contribute to the identification of PD patients who are prone to develop dyskinesia, and may be considered in future clinical trials aiming at developing new therapeutic approaches for PD.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.708019/2022-01)
This publication has 19 references indexed in Scilit:
- Using Smartphones and Machine Learning to Quantify Parkinson Disease SeverityJAMA Neurology, 2018
- Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an updateThe Lancet Neurology, 2017
- Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s diseaseJournal of Neurology, 2016
- Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periodsNeuropsychiatric Disease and Treatment, 2015
- Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's diseaseMovement Disorders, 2013
- Anti‐dyskinetic mechanisms of amantadine and dextromethorphan in the 6‐OHDA rat model of Parkinson’s disease: role of NMDA vs. 5‐HT1A receptorsEuropean Journal of Neuroscience, 2012
- MissForest—non-parametric missing value imputation for mixed-type dataBioinformatics, 2011
- The Parkinson Progression Marker Initiative (PPMI)Progress in Neurobiology, 2011
- Does laterality of motor impairment tell us something about cognition in Parkinson disease?Parkinsonism & Related Disorders, 2009
- Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatmentCurrent Neurology and Neuroscience Reports, 2007